Medpace Voice

Digestive Disease Week® is one of the largest congresses in the US in the fields of gastroenterology, hepatology and endoscopy....

Medpace oncology experts examine the clinical and operational concepts driving the next phase of oncology development presented at 2025 ASCO.

As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating...

Clinical and Regulatory Considerations for Advancing Urinary Tract Infection (UTI) Drug Development in Women

Explore insights from Medpace medical and operational experts as they identify key themes from ESCMID Global 2025.

In this webinar, experts provide a comprehensive overview of the current state of the clinical development landscape for rheumatology, along with strategies to drive success…

As biopharmaceutical companies seek to optimize clinical trial design, accelerate regulatory approvals, and improve patient outcomes, insights from JSMO 2025 provide a critical foundation for…

In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...

Every cancer journey is unique—shaped by the individual, the disease, and the evolving landscape of treatment.

Medpace medical, regulatory, and biostatistics experts identify key differences between the FDA’s 2007 and 2025 guidance documents on developing products...